What is antiphospholipid syndrome?

被引:23
作者
Erkan D. [1 ]
Lockshin M.D. [1 ]
机构
[1] Department of Rheumatolopgy, Hospital for Special Surgery, 535 E 70th Street, New York, 10021, NY
关键词
Anticardiolipin Antibody; Factor Versus Leiden Mutation; Pregnancy Morbidity; Thrombotic Risk Factor; Lupus Anticoagulant Test;
D O I
10.1007/s11926-004-0024-1
中图分类号
学科分类号
摘要
The description of antiphospholipid syndrome (APS) is vascular thrombosis and/or pregnancy morbidity occurring in persons with antiphospholipid antibodies (aPL). However, because of an unclear etiopathogenesis and the heterogeneous nature of aPL and of aPL-related clinical manifestations, a single, unambiguous definition of APS does not exist. In this paper, we describe a structured approach to APS, discuss the controversies, and offer descriptions of APS that include: an autoimmune systemic disease with a spectrum of (mostly thrombotic) clinical manifestations, an overdiagnosed disease when aPL is present but has no proven direct causative role in the clinical manifestations, and a disease of controversies that requires clarification of etiology and mechanisms and risk-stratified controlled clinical studies.
引用
收藏
页码:451 / 457
页数:6
相关论文
共 194 条
[1]  
Wilson WA(1999)International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop Arthritis Rheum 42 1309-1311
[2]  
Gharavi AE(2003)Treatment of the antiphospholipid syndrome N Engl J Med 349 1177-1179
[3]  
Koike T(1998)Antibodies against phospholipids and beta 2-glycoprotein I increase the risk of recurrent venous thromboembolism in patients without systemic lupus erythematosus QJM 91 125-130
[4]  
Lockshin MD(1997)The association of antibodies to beta 2 glycoprotein I with the antiphospholipid syndrome: a meta-analysis Ann Clin Lab Sci 27 41-46
[5]  
Erkan D(2004)Real world experience with antiphospholipid antibodies (aPL): how useful is anti-beta-2-Glycoprotein-I test? (abstract Arthritis Rheum 50 S67-S67
[6]  
Wahl DG(2003)Antiphospholipid antibodies and infections Ann Rheum Dis 62 388-393
[7]  
De Maistre E(2003)Etiology and pathogenetic mechanisms of the antiphospholipid syndrome unraveled Trends Immunol 24 2-4
[8]  
Guillemin F(2003)Viral origin of antiphospholipid antibodies: endothelial cell activation and thrombus enhancement by CMV peptide-induced APL antibodies Immunobiology 207 37-42
[9]  
Najmey SS(2004)Antiphospholipid syndrome infectious origin J Clin Immunol 24 12-23
[10]  
Keil LB(2003)Current status and implications of autoimmune antiphospholipid antibodies in relation to thrombotic disease J Thromb Haemost 1 931-942